Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating activities:
Net loss	$ (1,367)	$ (918)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of acquisition-related intangible assets	4,950	5,326
Stock-based compensation plan expense	11,044	12,342
Depreciation and other amortization	6,092	5,640
Gain on sale of cost-method investment	0	(237)
Deferred income tax benefit	(368)	(1,794)
Provision for allowances on accounts receivable	67	44
Amortization of debt issuance costs	103	104
Amortization of discount on investments	(28)	(37)
Loss on disposal of equipment	35	592
Loss on foreign exchange	259	126
Changes in operating assets and liabilities:
Accounts receivable	11,025	5,239
Prepaid expenses and other current assets	(3,268)	(2,031)
Operating lease right-of-use asset, net	975
Other assets	(1,077)	(955)
Accounts payable	1,214	246
Accrued expenses	(571)	(2,828)
Operating lease liabilities	(823)
Customer account liabilities	1,609	496
Deferred revenue	(11,969)	(9,086)
Other liabilities	210	(287)
Net cash provided by operating activities	18,112	11,982
Investing activities:
Acquisition of businesses and assets, net of cash and restricted cash acquired	0	(8,895)
Purchases of other investments	(87)
Proceeds from sale of cost-method investment	0	237
Purchases of available-for-sale securities	6,274	2,665
Proceeds from sales of available-for-sale securities	3,700	2,700
Capital expenditures, including capitalization of software costs	(11,449)	(8,378)
Net cash used in investing activities	(14,110)	(17,001)
Financing activities:
Repurchase of common stock	(10,005)	0
Repayment of amounts borrowed under revolving credit facility	0	(40,000)
Repayment of notes payable	(182)	(183)
Settlement of warrants	0	(4)
Debt issuance costs related to credit facility	0	(597)
Proceeds from exercise of stock options and employee stock purchase plan	2,174	1,718
Net cash used in financing activities	(8,013)	(39,066)
Effect of exchange rate changes on cash	(1,970)	(946)
Decrease in cash, cash equivalents and restricted cash	(5,981)	(45,031)
Cash, cash equivalents and restricted cash at beginning of period	97,801	124,613
Cash, cash equivalents and restricted cash at end of period	91,820	79,582
Cash and cash equivalents at end of period	84,751	76,371
Cash held for customers at end of period	7,069	3,211
Cash, cash equivalents and restricted cash at end of period	91,820	79,582
Supplemental disclosures of non-cash financing activities:
Issuance of common stock upon settlement of the warrants	$ 0	$ 55,796